More topics

Limited coverage criteria – insulin detemir

Last updated on March 18, 2025

 

Return to Special Authority drug list

Generic name

 insulin detemir 

Strength & form

 100 U/mL solution for injection, solution for injection in a pre–filled pen

Special Authority criteria

Approval period

Type 1 Diabetes – Patient of any age

Patient has a diagnosis of Type 1 Diabetes requiring insulin and is currently taking insulin NPH and/or pre-mix insulin daily at optimal dosing

AND

  • Has experienced unexplained nocturnal hypoglycemia at least once a month despite optimal management

OR

  • Has experienced or continues to experience severe, systemic or local allergic reaction to existing insulin treatment

Indefinite

Type 2 Diabetes – Patient over 17 years of age only

Patient has a diagnosis of Type 2 Diabetes requiring insulin and is currently taking insulin NPH and/or pre-mix insulin daily at optimal dosing

AND

  • Has experienced unexplained nocturnal hypoglycemia at least once a month despite optimal management

OR

  • Has experienced or continues to experience severe, systemic or local allergic reaction to existing insulin treatment

Indefinite

Practitioner exemptions

  • Practitioners in endocrinology are not required to submit a Special Authority Request form for coverage

Special notes

  • Specialists with experience in pediatric diabetes management may also have prescriptions covered for patients who meet the coverage criteria, but are required to submit a Special Authority request
  • When requesting coverage for patients who have experienced severe, systemic or local allergic reaction to existing insulin treatment, documentation of previous trials (i.e., specific insulin tried and patient's response) is required

Special Authority request form(s)